Clinical Trials

Clinical Trials Search Results

Search By Keywords or Choose a Category 

Showing 1-3 of 3

Sorted By:

  • AFT-19

    A study in men with biochemically recurrent prostate cancer and PSA doubling time = 9 months at the time of study entry.

  • NRG GU008 (INNOVATE)

    This phase III trial studies how well adding apalutamide, abiraterone acetate, and prednisone to the usual hormone therapy and radiation therapy works compared to the usual hormone therapy and radiation therapy in treating patients with node-positive prostate cancer after surgery.

  • SWOG S1802

    This phase III trial studies how well standard systemic therapy with or without definitive treatment works in treating participants with prostate cancer that has spread.